Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Victoza in early diagnosed type 1 diabetes
NCT02908087Phase 2Completed
- Sponsor
- University of Oulu
- Start
- Mar 2016
- Primary completion
- May 2021
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of liraglutide in type 1 diabetes mellitus (T1D), sponsored by University of Oulu. Started Mar 2016; status: completed.
02
Drugs
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02908087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02908087.